TuHURA Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HURA and other ETFs, options, and stocks.About HURA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco
CEOJames A. Bianco
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded2023
Founded2023
Employees19
Employees19
HURA Key Statistics
Market cap46.56M
Market cap46.56M
Price-Earnings ratio-1.17
Price-Earnings ratio-1.17
Dividend yield—
Dividend yield—
Average volume279.11K
Average volume279.11K
High today$0.78
High today$0.78
Low today$0.7517
Low today$0.7517
Open price$0.7608
Open price$0.7608
Volume274.40K
Volume274.40K
52 Week high$5.27
52 Week high$5.27
52 Week low$0.70
52 Week low$0.70
Stock Snapshot
With a market cap of 46.56M, TuHURA Biosciences(HURA) trades at $0.78. The stock has a price-to-earnings ratio of -1.17.
As of 2026-01-19, TuHURA Biosciences(HURA) stock has fluctuated between $0.75 and $0.78. The current price stands at $0.78, placing the stock +3.3% above today's low and -0.5% off the high.
The TuHURA Biosciences(HURA)'s current trading volume is 274.4K, compared to an average daily volume of 279.11K.
During the past year, TuHURA Biosciences(HURA) stock moved between $0.70 at its lowest and $5.27 at its peak.
During the past year, TuHURA Biosciences(HURA) stock moved between $0.70 at its lowest and $5.27 at its peak.
People also own
Based on the portfolios of people who own HURA. This list is generated using Robinhood data, and it’s not a recommendation.